Login
$IVF
$0.54 -$0.02 (3.6%) Close

$IVF 4 SEC Filings

Filed On Filing
05 Dec 2025 Form 4: Szot Matthew K, Director

Sold 4 shares ($6.08) · Disposed of 3 shares (Other Transaction)

03 Oct 2025 Form 4: Shum Steve, Director

Granted 42,000 Stock Option (right to buy)

28 Aug 2025 Form 4: Szot Matthew K, Director

Granted 45,000 Stock Option (right to buy)

28 Aug 2025 Form 4: Ryan Barbara, Director

Granted 45,000 Stock Option (right to buy)

28 Aug 2025 Form 4: Goren Andrea, Chief Financial Officer

Granted 50,000 Stock Option (right to buy)

28 Aug 2025 Form 4: Davis Trent D, Director

Granted 45,000 Stock Option (right to buy)

28 Aug 2025 Form 4: Messina Rebecca, Director

Granted 45,000 Stock Option (right to buy)

22 May 2023 Form 4: Szot Matthew K, Director

Granted 85,000 Stock Option (right to buy)

22 May 2023 Form 4: Shum Steve, Director

Granted 100,000 Stock Option (right to buy)

22 May 2023 Form 4: Ryan Barbara, Director

Granted 85,000 Stock Option (right to buy)

22 May 2023 Form 4: Messina Rebecca, Director

Disposed of 85,000 Stock Option (right to buy) (Grant/Award Acquisition)

22 May 2023 Form 4: Goren Andrea, Chief Financial Officer

Granted 81,000 Stock option (right to buy)

22 May 2023 Form 4: Davis Trent D, Director

Granted 85,000 Stock Option (right to buy)

22 May 2023 Form 4: Campbell Michael Jos., Director

Granted 83,000 Stock Option (right to buy)

03 Jun 2022 Form 4: Shum Steve, Director

Bought 58,885 shares ($55.9K)

03 Jun 2022 Form 4: Szot Matthew K, Director

Bought 14,474 shares ($13.8K)

03 Jun 2022 Form 4: Ryan Barbara, Director

Bought 10,526 shares ($10K)

03 Jun 2022 Form 4: Davis Trent D, Director

Bought 11,184 shares ($10.6K)

03 Jun 2022 Form 4: Segal Jeffrey, Director

Bought 9,211 shares ($8.75K)

03 Jun 2022 Form 4: Campbell Michael Jos., Director

Bought 10,526 shares ($10K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support